Delayed Onset Muscle Soreness (DOMS)
13
1
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 10 completed trials
Clinical Trials (13)
Real-world Evidence of Cannabinoid for Observed Pain Relief
PNF Versus Cryotherapy in Delayed Onset Muscle Soreness
Isometric Exercise for Delayed Onset Muscle Soreness
Effectiveness of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Myofascial Release in Reducing Delayed Onset Muscle Soreness (DOMS) in the Cervicothoracic Region
Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness
Effects of Immediate and Delayed Repeated Cold Exposure After Physical Exertion
Comparison of the Effects of Kinesio Taping and Graston Application in Individuals With Delayed Onset Muscle Soreness
Posterior Chain Responses to Gastrocnemius DOMS
Walk It Off! the Influence of Physical Activity Level on the Recovery from Damaging Resistance Exercise
The Effect of Percussion Massage Therapy on the Recovery of DOMS in Physically Active Young Men Delayed Onset Muscle Soreness = DOMS
Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity
COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS)
Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)